Sotera Health

Sotera Health

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $35M

Overview

Sotera Health operates as essential infrastructure for the global healthcare supply chain, integrating three long-established businesses to offer a comprehensive suite of sterilization and safety testing services. The company serves a blue-chip customer base, including 40 of the top 50 medical device firms, leveraging a multi-modal sterilization network and a proprietary Cobalt-60 supply chain. Its strategy is built on providing mission-critical, regulatory-required services that are deeply embedded in customers' product lifecycles, creating a resilient and recurring revenue model.

DiagnosticsMedical Devices

Technology Platform

A comprehensive, multi-modal physical network of sterilization technologies (Gamma, EtO, Ebeam, X-ray) integrated with a proprietary Cobalt-60 supply chain and global analytical lab services for product safety validation.

Funding History

2
Total raised:$35M
Series B$25M
Series A$10M

Opportunities

Underlying growth in medical device and pharmaceutical innovation drives steady demand for sterilization and testing.
The trend towards outsourcing non-core, capital-intensive functions by healthcare manufacturers benefits specialized leaders.
Expansion of food irradiation for pathogen control presents a long-term adjacent market opportunity.

Risk Factors

Significant regulatory and litigation risk surrounding ethylene oxide (EtO) emissions could lead to substantial capital expenditures, operational constraints, or financial liabilities.
High financial leverage limits flexibility and amplifies downside risk.
Operational risks related to handling hazardous materials pose threats to business continuity and reputation.

Competitive Landscape

Competes in fragmented but consolidating markets. In sterilization, key rivals are Steris and BD; in lab testing, large CROs like Charles River and Eurofins. Differentiated by pure-play focus, multi-modal global network, and vertical integration via Cobalt-60 supply. High barriers to entry protect market position.